Royal Bank of Canada reaffirmed their outperform rating on shares of Biohaven (NYSE:BHVN – Free Report) in a research note published on Tuesday morning, Benzinga reports. Royal Bank of Canada currently has a $61.00 price objective on the stock. A number of other research analysts have also weighed in on BHVN. HC Wainwright raised their […]
Related Keywords
Canada , , Biohaven Ltd , Perceptive Advisors , Legato Capital Management , Monashee Investment Management , Simon Quick Advisors , Citigroup Inc , Royal Bank , Jpmorgan Chase Co , Biohaven Company Profile , Free Report , Get Free Report , Quick Advisors , Capital Management , Investment Management , Taldefgrobep Alfa , Biohaven Daily , Biohaven , Nyse Bhvn , Bhvn , Medical , Reiterated Rating , Royal Bank Of Canada ,
comparemela.com © 2020. All Rights Reserved.